Latest News
June 21, 2017

Resources for Family Caregivers Offered by the Alzheimer’s Association

Caring for a family member with Alzheimer’s disease is among the toughest personal journeys someone can make. To make life for caregivers easier, the Alzheimer’s Association […]
June 12, 2017

3 New Studies Will Add to IDEAS Research on Dementia Causes and Care

The $100 million IDEAS (Imaging Dementia — Evidence for Amyloid Scanning) Study is working closely with researchers and government officials to add three additional studies to the main project, where […]
June 8, 2017

Supply of ‘Ready-to-Test’ Mice Being Made Available to Alzheimer’s Researchers

Taconic Biosciences is improving its services to Alzheimer’s disease researchers — creating a ready-to-use stock of an important mouse model of the disease. Earlier procedures forced researchers […]
June 8, 2017

Preventing Diabetes May Help Halt Alzheimer’s Progression in New York State, Report Says

The state of New York lacks effective measures for preventing diabetes, which is fueling a dramatic increase in Alzheimer’s disease. So says a new document, “Unprevented Diabetes Means Unnecessary Alzheimer’s,” […]
June 7, 2017

Axsome’s Therapy for Agitation in Alzheimer’s Granted FDA Fast Track Designation

Axsome Therapeutics’ investigational drug AXS-05 was recently granted fast track designation by the U.S. Food and Drug Administration (FDA) for the treatment of agitation in patients […]
June 7, 2017

Music Therapy Decreases Medication Use and Improves Dementia Symptoms, Study Finds

A new study found personalized music therapy helped decrease antipsychotic and anti-anxiety medication use, as well as improve dementia symptoms, in people living with Alzheimer’s disease […]
June 7, 2017

Alzheimer’s Deaths in U.S. Increased 55% in 15-Year Span, CDC Study Reveals

In a recent Morbidity and Mortality Weekly Report from the Centers for Disease Control and Prevention (CDC), researchers show that deaths due to Alzheimer’s disease increased […]
June 7, 2017

Dementia Caregivers Pay High Emotional Toll, Need More Support, Surveys Say

Two surveys released today — the start of Alzheimer’s disease month — examine the emotional toll the condition places on caregivers, and their need for greater support. […]
June 7, 2017

Cognitive Tests May Help Detect Early Alzheimer’s in Patients Without Symptoms

A Keck School of Medicine of USC study shows that cognitive tests can detect early Alzheimer’s disease in  older adults who do not present symptoms yet. […]
June 7, 2017

Phase 1 Trial Begins Evaluating Safety of Focused Ultrasound in Alzheimer’s Patients

Insightec’s new platform, Exablate Neuro, is to be a part of the first-ever clinical trial (NCT02986932) evaluating the safety and feasibility of opening the blood-brain barrier […]
June 7, 2017

$1.7 Million NIH Grant to Fund Pain Therapeutics’ Study of PTI-125 as Candidate for Alzheimer’s Treatment

The National Institutes of Health (NIH) has awarded Pain Therapeutics a $1.7 million research grant to study PTI-125 as a potential treatment for Alzheimer’s disease. ReadMore…
June 1, 2017

Otsuka and Avanir to Help Start an Alzheimer’s Assistants Training Program in New Jersey

Otsuka America Pharmaceutical and Avanir Pharmaceuticals are working with southern New Jersey educational administrators to create specialists who can help Alzheimer’s patients and their families navigate the care continuum. […]
June 1, 2017

Seizure-Like Brain Activity May Contribute to Alzheimer’s Development, Study Reports

Epileptic-seizure-like activity in a brain region called the hippocampus may contribute to the development of Alzheimer’s, according to a case study involving two patients. ReadMore…
June 1, 2017

Sangamo’s Research in Alzheimer’s Significantly Reduced Tau Levels in Mice

Promising data from Sangamo Therapeutics‘ research programs, including Alzheimer’s disease, were recently announced. ReadMore…
June 1, 2017

Acadia Investigates Nuplazid (Pimavanserin) Therapy to Treat Psychosis in Alzheimer’s Patients

Acadia Pharmaceuticals plans to start a Phase 3 clinical program to explore the effect of Nuplazid (pimavanserin) in Alzheimer’s disease patients with psychosis. The medication was […]
June 1, 2017

DNA Vaccine May Protect Against Accumulation of Toxic Amyloid in Alzheimer’s

A new DNA vaccine protects against accumulation of toxic proteins in Alzheimer’s disease, according to new research. ReadMore…
April 10, 2017

Angry at the World

During my family’s journey with Alzheimer’s/Dementia, I have made it a point to be as transparent as possible. Anger & fear play a big role in […]
February 1, 2017

Genervon stocks Alzheimer’s Gene listing connected to Its GM6 treatmentG

Gevervon Biopharmaceuticals Recently shared a previously exclusive list of 84 genes related to Alzheimer’s sickness which might be modulated by way of their investigational remedy GM6. […]